Marchex, Inc. - Class B Common Stock (MCHX)

Marchex posted mixed Q2 2025 results with revenue missing estimates but adjusted EBITDA and EPS improving. AI-driven growth and new partnerships signal future potential despite short-term challenges.

MCHX stock results show that Marchex missed on revenue for the fourth quarter of 2023.

MCHX stock results show that Marchex met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

MCHX stock results show that Marchex met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

The Dow Jones closed higher by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Gainers

  Marchex (NASDAQ:MCHX) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:20 PM. Here's what investors need to know about the announcement. Earnings Marchex reported in-line EPS of $-0.01 versus an estimate of $-0.01.

 

Marchex (NASDAQ:MCHX) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:20 PM. Here's what investors need to know about the announcement. Earnings Marchex beat estimated earnings by 50.0%, reporting an EPS of $-0.01 versus an estimate of $-0.02.